Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations? by Blandina, Patrizio et al.
MINI REVIEW ARTICLE
published: 04 May 2012
doi: 10.3389/fnsys.2012.00033
Histamine neurons in the tuberomamillary nucleus:
a whole center or distinct subpopulations?
Patrizio Blandina*, Leonardo Munari, Gustavo Provensi and Maria B. Passani
Dipartimento di Farmacologia Preclinica e Clinica, Universitá degli Studi di Firenze, Firenze, Italy
Edited by:
Pertti Panula, University of Helsinki,
Finland
Reviewed by:
Christine E. Collins, Vanderbilt
University, USA
Helmut Haas, Heinrich-
Heine-Universität, Germany
Paul Chazot, Durham University, UK
*Correspondence:
Patrizio Blandina, Dipartimento di
Farmacologia Preclinica e Clinica,
Universitá degli Studi di Firenze,
Viale G. Pieraccini 6,
50139 Firenze, Italy.
e-mail: patrizio.blandina@unifi.it
Histamine axons originate from a single source, the tuberomamillary nucleus (TMN)
of the posterior hypothalamus, to innervate almost all central nervous system (CNS)
regions. This feature, a compact cell group with widely distributed fibers, resembles
that of other amine systems, such as noradrenaline or serotonin, and is consistent
with a function for histamine over a host of physiological processes, including the
regulation of the sleep-wake cycle, appetite, endocrine homeostasis, body temperature,
pain perception, learning, memory, and emotion. An important question is whether these
diverse physiological roles are served by different histamine neuronal subpopulation.
While the histamine system is generally regarded as one single functional unit that
provides histamine throughout the brain, evidence is beginning to accumulate in favor of
heterogeneity of histamine neurons. The aim of this review is to summarize experimental
evidence demonstrating that histamine neurons are heterogeneous, organized into
functionally distinct circuits, impinging on different brain regions, and displaying selective
control mechanisms. This could imply independent functions of subsets of histamine
neurons according to their respective origin and terminal projections.
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HISTAMINERGIC CELL BODIES ARE RESTRICTED TO
THE TUBEROMAMILLARY NUCLEUS
In neurons histamine is synthesized through decarboxylation of
L-histidine by a specific histidine decarboxylase (E.C.4.1.1.22;
HDC) (Green et al., 1987). In a comparable manner to the archi-
tecture of noradrenergic, dopaminergic, and serotonergic systems
(Mason and Fibiger, 1979; Jacobs and Azmitia, 1992), histamine
neurons are restricted to discrete cell clusters in the tuberomamil-
lary nucleus (TMN) of the posterior hypothalamus (Watanabe
et al., 1983; Panula et al., 1984), and send mostly unmyeli-
nated axons to the entire central nervous system (CNS; Inagaki
et al., 1988; Airaksinen et al., 1989). Catecholaminergic and
serotonergic nuclei are clustered in distinct compartments with
respect to projection fields, as sets of axons innervating separate
brain regions originate from separate subgroups of noradrenergic
(A1–A7), dopaminergic (A8–A17) and serotonergic (B1–B9)
neurons (Mason and Fibiger, 1979; Jacobs and Azmitia, 1992).
This pattern implies independent functions of sets of neurons
according to their origin and terminal projections. This does
not seem to be the case for the histaminergic system, as ret-
rograde tracers injected into different CNS regions labeled his-
taminergic somata scattered throughout the TMN without a
strict topographical pattern (Köhler et al., 1985; Inagaki et al.,
1990). Moreover, histaminergic efferents present diffuse varicosi-
ties containing synaptic vesicles, but form synaptic contacts only
infrequently (Takagi et al., 1986; Tohyama et al., 1991; Michelsen
and Panula, 2002). This feature and the lack of a high-affinity
uptake mechanism specific for histamine in the CNS suggest that
histamine may diffuse from the site of release and has widespread
effects, thus acting as a local hormone affecting not only neu-
ronal, but also glial activity and blood vessel tone (Wada et al.,
1991b). These features are compatible with reports of mismatches
between distribution of histaminergic fibers and histaminergic
receptors (Pillot et al., 2002; Haas et al., 2008), and have led to the
concept that the histaminergic regulation of a wide range of brain
functions, ranging from basic homeostasis such as sleep-wake
rhythm, thermoregulation, food intake to emotions, learning,
and memory (Haas et al., 2008; Passani et al., 2011), is achieved
by the histaminergic system as a whole (Wada et al., 1991b).
HISTAMINE IS INVOLVED IN MANY BRAIN FUNCTIONS
Although several characteristics of histaminergic neurons empha-
size their broadmodulatory function, namely their diffuse projec-
tions as well as their capacity to release histamine at non-synaptic
sites, other features, such as the existence of synaptic contacts
and the demonstration of a tight temporal control, suggest that
histamine can exert more discrete actions at specific brain loci
(Inagaki et al., 1987; Haas et al., 2008). Indeed, the histaminer-
gic system can implement many functions, including the arousal
state, brain energy metabolism, locomotor activity, neuroen-
docrine, autonomic, and vestibular functions, feeding, drinking,
sexual behavior, and analgesia, presumably by engaging inde-
pendent subpopulations of histaminergic neurons according to
the brain regions required for a particular behavioral outcome.
Consistent with this hypothesis, heterogeneity within the his-
taminergic neuronal population in response to stress (Miklos
and Kovacs, 2003) and pharmacological stimulations was recently
reported (Blandina et al., 2010; Passani and Blandina, 2011).
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HETEROGENEITY OF HISTAMINE NEURONS IN RESPONSE
TO STRESS
In the rat brain histaminergic, neuronal somata are grouped
within the TMN in five clusters, E1–E5, each of which sends over-
lapping projections throughout the neuroaxis with a low level
of topographical organization, and bridged by scattered neurons
(Ericson et al., 1987; Inagaki et al., 1988, 1990). A similar pat-
tern of distribution has been reported in the brains of other
mammals and non-mammalian vertebrates (Wada et al., 1991a).
Histamine release is a sensitive indicator of stress (Verdiere et al.,
1977; Westerink et al., 2002). Indeed, restraint and/or metabolic
stress are among the most potent activators of histamine neurons.
Different types of stress (Miklos and Kovacs, 2003), as well as
hypercapnic loading (Haxhiu et al., 2001) activated only selected
subgroups of histaminergic neurons. These findings rely on the
measurement of c-fos immunocytochemistry, a marker of cell
activation, in histamine neurons identified with in situ hybridiza-
tion of HDC mRNA. Under stress-free, basal conditions c-fos
expression was detected in a negligible number of histamine neu-
rons (less than 1%) distributed uniformly in the TMN (Miklos
and Kovacs, 2003). Following restraint, up to 36% of histamine
neurons in E4 and E5 regions became c-fos positive, but signifi-
cantly fewer, less than 10%, were activated in E1, E2, or E3 regions
(Miklos and Kovacs, 2003). Moreover, different types of stress,
foot shock or insulin-induced hypoglycemia, activated E4 and
E5 histamine neurons, but failed to induce any significant c-fos
activation in the histamine neurons of the three remaining clus-
ters. Therefore, stress-sensitive histamine neurons were detected
in the rostral (E4–E5) subgroups rather than in the caudal ones
(E1–E3), clearly indicating that histaminergic neurons of distinct
TMN clusters are recruited in a stressor- and subgroup-specific
manner (Miklos and Kovacs, 2003).
In line with the concept of heterogeneity of these neurons, only
a subset of histaminergic neurons (E2) responded to hypercap-
nic stress (CO2 exposure) with an increase of c-fos expression
(Haxhiu et al., 2001; Johnson et al., 2005). Consistently, record-
ings in rat brain slices revealed that acidification within the phys-
iological range excited E2 neurons localized in the ventrolateral
TMN. The excitation is mediated by both metabotropic gluta-
mate receptors and acid sensing ion channels (ASICs; Yanovsky
et al., 2012) that are expressed at significantly higher density in
the ventrolateral TMN than in the medial part (Yanovsky et al.,
2012). The functional significance of chemosensory traits in his-
taminergic neurons is not well known. However, it is expected
that activation of histamine neurons by an increase in CO2 and/or
H+ may affect central respiratory drive through activation of neu-
rons in the nucleus tractus solitarius, a region displaying a dense
network of histaminergic fibers (Airaksinen and Panula, 1988;
Airaksinen et al., 1989).
HETEROGENEITY OF HISTAMINE NEURONS IN RESPONSE
TO GABA AND GLYCINE
Heterogeneity within the histaminergic neuron population was
shown also using a different approach. It is well established that
the activity of histamine neurons is closely associated with the
behavioral state: in behaving cats, rats, and mice, the firing is
more variable during waking and absent upon drowsiness and
during sleep. This is the most wake-selective firing pattern identi-
fied in the brain to date (Lin, 2000; Lin et al., 2011). Sleep-active,
GABAergic neurons in the ventrolateral preoptic nucleus (VLPO)
provide a major input to the TMN, and may play a key role
in silencing the ascending histaminergic arousal system during
sleep (Sherin et al., 1998). Interestingly, GABA release in the pos-
terior hypothalamus increased during SWS, and microinjection
of the GABAA-receptor (GABAA-R) agonist muscimol, into the
same area increased SWS time (Nitz and Siegel, 1996). Hence,
GABA release in the posterior hypothalamus inhibits directly
histaminergic cells firing rate (Yang and Hatton, 1997), thereby
facilitating SWS, whereas GABAA-R inhibition increases signifi-
cantly the release of histamine from the TMN, as measured with
microdialysis (Cenni et al., 2006). Electrophysiological studies
using whole-cell recording identified two subpopulations among
histamine neurons isolated from the TMN according to their
sensitivity to GABA (Sergeeva et al., 2002), with GABA concentra-
tions for threshold and maximal responses ranging between 0.5
and 5µM in one subpopulation, and between 50 and 500µM in
the other one (Sergeeva et al., 2002). GABA responses were com-
pletely blocked by gabazine, a selective antagonist of GABAA-R
(Sergeeva et al., 2002). This receptor is a protein complex assem-
bled from a family of 19 homologous subunit gene products that
form mostly hetero-oligomeric pentamers. The major isoforms
contain alpha, beta, and gamma subunits and show differential
sensitivity to GABA, to modulators like steroids, to physiological
regulation, and to disease processes (Olsen and Sieghart, 2009).
Sergeeva and coworkers (Sergeeva et al., 2002), using whole-cell
recording and single cell RT-PCR from isolated rat histamine
neurones, characterized GABAA-R evoked currents and corre-
lated them with the expression patterns of 12 GABAA-R subunits.
They identified three different groups of histamine neurons on
the basis of their gamma subunits expression. The occurrence
of each gamma subunit was correlated with GABA EC50. The
group expressing both gamma1 and gamma2 subunits displayed
a high sensitivity to GABA, whereas the group expressing only the
gamma2 subunit displayed a low sensitivity. Histaminergic neu-
rons are also heterogeneous with respect to their sensitivity to
glycine that correlates with their size. Indeed, the maximal glycine
response (1mM) in histaminergic cells with larger somata (25µ)
was about half of the maximal GABA response whereas in the cells
with a smaller soma size (19.5µ) the glycine response was absent
or very small (Sergeeva et al., 2001).
HISTAMINE NEURONS ESTABLISH FUNCTIONALLY DISTINCT
PATHWAYS ACCORDING TO THEIR TERMINAL PROJECTIONS
In our laboratory we addressed the question of whether his-
taminergic neurons are organized into distinct functional circuits
impinging on different brain regions. We used the double-probe
microdialysis technique in freely moving animals, which provides
a powerful means for defining the dynamics regulating histamine
release in discrete brain regions. Rats were implanted with one
probe in the TMN, to deliver drugs andmeasure histamine release
locally, and another probe to measure histamine release from
histaminergic projection areas such as the prefrontal cortex, the
nucleus basalis magnocellularis (NBM), the nucleus accumbens
(NAcc) or the dorsal striatum. By applying compounds targeting
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receptors expressed on histamine neurons and measuring his-
tamine output in different brain areas, we demonstrated that
the same drug influenced differently the release of histamine
from distinct brain regions. Bicuculline, a GABAA-R antagonist,
acts directly onto histaminergic neurons to augment cell firing
(Haas et al., 2008). We found that intra-hypothalamic perfu-
sion of bicuculline increased histamine release from the TMN,
the NAcc and the prefrontal cortex, but not from the striatum
(Giannoni et al., 2009) (Table 1). Different subunit composition
and stoichiometry of GABAA-Rs among histaminergic neurons
(Sergeeva et al., 2002, 2005) may account for these results. It is
worth noting that functional heterogeneity of responses to bicu-
culline among histaminergic neurons relates to TMN neurons
heterogeneity with respect to projection fields. Also, responses to
histamine 3 receptor (H3-R) antagonists differentiate histamin-
ergic neurons according to their projection areas. When applied
to the rat TMN, H3-R antagonists, such as thioperamide or the
more recently synthesized, non-imidazole compounds as GSK-
189254, invariably augmented histamine release from the TMN,
from the prefrontal cortex and from the NBM, but not from the
NAcc, nor the striatum (Giannoni et al., 2009, 2010) (Table 1).
The H3-R is present on presynaptic terminals and varicosities of
histaminergic axons, where it moderates histamine synthesis and
release (Arrang et al., 1983, 1985). H3-Rs are also located on his-
taminergic neuronal somata, and provide a tonic inhibition (Haas
and Panula, 2003) by modulating inward Ca++ currents (Reiner,
1987; Takeshita et al., 1998; Stevens et al., 2001). Therefore, block-
ade of somatic and presynaptic H3-autoreceptors increase cell
firing (Haas and Panula, 2003) and augment histamine levels in
the synaptic cleft. In the TMN, histamine is released from short
projections that form extensive axonal arborizations in the pos-
terior hypothalamus. Thioperamide or GSK-189254 were applied
locally through the microdialysis probe to the TMN (Giannoni
et al., 2009, 2010), hence histamine output increased as a conse-
quence of both somatic and presynaptic H3-autoreceptors block-
ade, although the participation of only one component cannot
be excluded. Thioperamide or GSK-189254, applied locally into
the TMN, significantly increased histamine release also from the
prefrontal cortex, and the NBM, but histamine levels remained
stable in the dorsal striatum and NAcc. Increases in the prefrontal
cortex and NBM were likely due to discharge potentiation of his-
tamine neurons sending efferents to these regions, in a way similar
to the effects of TMN perfusion with prostaglandin E2 (Huang
et al., 2003), or Orexin-A (Huang et al., 2001). On the other
hand, the lack of increase in histamine release during TMN per-
fusion with H3-R antagonists observed in the dorsal striatum and
NAcc, despite the fact that these brain areas receive histaminer-
gic innervation (Panula et al., 1989), indicates that histaminergic
neurons projecting to these regions are insensitive to H3-R block-
ade. We further demonstrated that histaminergic neurons are not
a homogenous neuronal population using cannabinoid receptor
1 (CB1) agonists. Administration of methanandamide (mAEA)
or ACEA in the TMN facilitated histamine release from the TMN
itself, from the NBM and striatum as well (Cenni et al., 2006).
However, perfusion of the posterior hypothalamus with mAEA
did not change significantly histamine release from the perirhinal
cortex (Passani et al., 2007; Table 1) despite the profuse histamin-
ergic innervation of this region (Panula et al., 1989) and the
presence of histaminergic receptors (Pillot et al., 2002).
Spatial segregation due to probe localization does not explain
the lack of response, as retrograde tracing with dye injections
into the striatum or prefrontal cortex showed that most histamin-
ergic somata are within the medial part of the ventral TMN
(Köhler et al., 1985). This proximity suggests that histaminer-
gic somata projecting to the striatum and prefrontal cortex had
the same exposure to H3-R antagonists, but were not affected
in the same way. In conclusion, H3-R antagonists may discrim-
inate groups of histaminergic neurons impinging on different
brain regions, thus suggesting that these neurons are organized
into functionally distinct circuits that influence different brain
regions, and display selective control mechanisms. In keeping
with these results, activation of c-fos after GSK189254 admin-
istration occurred in cortical areas and the TMN, but not in
striatum (Medhurst et al., 2007). To explore the local effects of
H3-R blockade in the histaminergic projection areas, single-probe
microdialysis experiments were performed. Local perfusion with
H3-R antagonists in the NBM or prefrontal cortex augmented sig-
nificantly histamine release within these regions, an effect that
can be explained by blockade of local H3-autoreceptors. The
same drugs administered locally to the striatum or NAcc did not
modify histamine release, thus indicating that the whole soma-
todendritic domain of histaminergic neurons projecting to these
regions is insensitive to H3-R antagonists. Accordingly, lesion
experiments indicate that the vast majority of H3-Rs in the NAcc
and striatum are not associated with histaminergic fibers (Pollard
et al., 1993), which is consistent with high densities of H3-R
Table 1 | Influence of drug administration into the TMN on histamine release from different brain areas of freely moving rats.
Drugs administered into the TMN Histamine release Reference
TMN Cortex NBM Striatum NACC
Thioperamide Increase Increase Increase No change No change Giannoni et al., 2009
GSK189254 Increase Increase Increase No change No change Giannoni et al., 2010
Bicuculline Increase Increase No change No change Increase Giannoni et al., 2009
ACEA Increase NA Increase Increase NA Cenni et al., 2006
R(+)Methanandamide Increase No change Increase Increase NA Cenni et al., 2006;
Passani et al., 2007
NA, not available
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FIGURE 1 | Distribution of H3-R on TMN histaminergic neurons. (A,B)
HDC-positive cells in the E2–E3 subdivision of the TMN showing H3-R
fluorescence; (C,D) high resolution z-projections of H3-R expression in the
HDC-positive neurons selected in (B); (E) Average intensity of colocalised
signals. Analysis of immunocolocalization density was carried out on regions
of interest (ROI) of identical area (576 pixels), identified on randomly chosen
HDC-positive neurons that where entirely within the thickness of the
specimen and were not overlapping. An arbitrary level was set at an optical
density value of 20 arbitrary units. Shown are means ± SEM, ∗P < 0.05
(unpaired t-test). Observations were repeated in three rats with similar
results. Calibration bar; (A) 160mm; (B) 40mm; (C,D) 8mm. Modified from
Giannoni et al. (2009).
mRNAs levels in the same regions (Chazot et al., 2001; Cannon
et al., 2007), and suggests a postsynaptic localization of these
receptors. Indeed, H3-R are not restricted to histaminergic neu-
rons (Pollard et al., 1993), and they act also as heteroreceptors
modulating the release of neurotransmitters such as acetylcholine
(ACh), dopamine, glutamate, noradrenaline, or serotonin from
brain regions crucial for the maintenance of alertness or the
storage of information (Passani et al., 2004; Haas et al., 2008).
Although it is generally assumed that all histaminergic neurons
express H3-R, several isoforms displaying strong differences have
been described (Bongers et al., 2007). Hence, in vivo insensitivity
to H3-R antagonists may depend on high expression of partic-
ular isoforms. In this regard, another observation is intriguing.
The distribution of H3-R on TMN neurons was examined by
performing double immunofluorescence labeling with a combi-
nation of anti-H3-R and anti-HDC antibodies (Giannoni et al.,
2009). Polyclonal H3-R antibodies are directed against residues
349–358 of human and rat H3-R and were previously validated
(Chazot et al., 2001; Cannon et al., 2007). In the posterior lat-
eral hypothalamus, both HDC-positive and -negative cells show
H3-R immunostaining (Figure 1) The density of H3-R immuno-
labeling was very high in the cytoplasm and on cell membranes
of some HDC-positive cell and very low in others, as revealed
by confocal microscopy (for immunocytochemical procedures see
Cenni et al., 2006). A quantitative analysis was carried out count-
ing the number of pixels with colocalized signal on randomly
chosen neurons in hypothalamic brain sections from three rat
brains. Setting at 20 the optical density expressed in arbitrary
units, two histaminergic neuronal populations that differed sig-
nificantly for H3-R expression levels were found (Figure 1). Since
the magnitude of neuronal responses to extracellular signals may
depend, at least in part on membrane receptor density, one
might envisage that HDC-positive cells displaying very low lev-
els of H3-R immunoreactivity are those innervating the NAcc or
striatum.
CONCLUSIONS
Much has been learned over the past 25 years about the role of
histamine as a neurotransmitter. Histamine is found in TMN
neurons that are active during wakefulness and exert multiple
functions. Indeed, histamine has a major role in maintenance
of arousal and contributes to modulation of circadian rhythms,
energy, and endocrine homeostasis, motor behavior, and cogni-
tion. The extent to which these diverse physiological roles are
served by different functional histamine systems is unclear, how-
ever, there is much experimental evidence suggesting that the
histaminergic system is organized into distinct pathways mod-
ulated by selective mechanisms. This could imply independent
functions of subsets of histaminergic neurons according to their
respective origin and terminal projections. Consequences could
be relevant for the development of specific compounds that affect
only subsets of HA cells, thus increasing the target specificity.
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